 | Up a level |
Journal Article
Duffy, David J., Krstic, Aleksandar 
ORCID: 0000-0002-7128-5707, Halasz, Melinda ORCID: 0000-0002-6175-9630, Schwarzl, Thomas ORCID: 0000-0001-7697-7000, Fey, Dirk ORCID: 0000-0002-5558-0167, Iljin, Kristiina, Mehta, Jai Prakash, Killick, Kate, Whilde, Jenny, Turriziani, Benedetta, Haapa-Paananen, Saija, Fey, Vidal, Fischer, Matthias, Westermann, Frank, Henrich, Kai-Oliver, Bannert, Steffen, Higgins, Desmond G. and Kolch, Walter ORCID: 0000-0001-5777-5016
(2015).
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.
Oncotarget, 6 (41).
S. 43182 - 43202.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Fey, Dirk ORCID: 0000-0002-5558-0167, Halasz, Melinda ORCID: 0000-0002-6175-9630, Dreidax, Daniel, Kennedy, Sean P., Hastings, Jordan F., Rauch, Nora ORCID: 0000-0001-6009-5177, Munoz, Amaya Garcia, Pilkington, Ruth, Fischer, Matthias, Westermann, Frank, Kolch, Walter ORCID: 0000-0001-5777-5016, Kholodenko, Boris N. and Croucher, David R.
(2015).
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.
Sci. Signal., 8 (408).
WASHINGTON:
AMER ASSOC ADVANCEMENT SCIENCE.
ISSN 1937-9145